Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
There is a substantial heterogeneity in adoption of multi-gene assays in Europe.
In a survey among physicians with at least 5 years of experience in treatment of breast cancer, a majority of respondents indicated they would use multi-gene assays in clinical practice, but the main perceived barriers for usage are reimbursement, price and lack of availability, according to the survey results presented by Dr Matti Aapro of the Multidisciplinary Oncology Institute, Geneva, Switzerland.
Read the article in full here.
Source: ESMO
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.